Home / Indicator library / Biotechnology and Medical Care / Level (3118) overview
Level (3118) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for Level, on one pageLevel (3118) snapshot, key figures
Level (3118): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 243 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→3118: common questions
What is 3118's P/E ratio?
3118 traded at a price-to-earnings ratio of 13.30x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 3118's dividend yield?
3118's cash dividend yield was 6.95% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.
How fast is 3118's revenue growing?
3118 reported -3.6% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 3118's price / earnings high or low right now?
3118's price / earnings is 13.30x, which is below its one-year median of 13.58x and sits at the 21st percentile of the 13.00–16.08x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Is 3118's dividend yield high or low right now?
3118's dividend yield is 6.95%, which is above its one-year median of 5.54% and sits at the 97th percentile of the 5.28–7.11% range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.